Antibiotic choice for COPD with pneumonia in ICU
Treatments studied
Part of Lungs & breathing clinical trials.
This trial is testing a new way to choose antibiotics for people with COPD who get pneumonia and need intensive care. The goal is to find the best treatment using a personalized approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have COPD (chronic obstructive pulmonary disease)
- You have pneumonia that started in the community (not in the hospital) and you are in the intensive care unit (ICU)
- You have been in the hospital for less than 48 hours
- You do not have a severely weakened immune system (for example, from cancer, HIV, or long-term steroids)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether using fast test results (PCR from samples, a blood marker called procalcitonin, and sputum appearance) can safely reduce how long you need antibiotics during a severe COPD flare. It may help you receive fewer days of antibiotics while still controlling the infection risk.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This trial is looking at patients with a serious worsening of their chronic obstructive pulmonary disease (COPD) who need intensive care. It aims to gather information to help improve treatment for these severe episodes.
This study looks at how well antibiotics work for pneumonia caused by a specific bacterium (Stenotrophomonas maltophilia) in patients who are on breathing machines in the intensive care unit (ICU). It will help doctors choose the best treatment.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
This trial compares customized durations of antibiotics to standard durations for treating acute worsening of COPD. It aims to see if stopping antibiotics early when symptoms improve is as effective as the usual fixed course.
Hear when a new To Reduce Duration of Antibiotics Exposure in Patients With COPD Hospitalized in Intensive Care Unit With Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.